Masimo Co. (MASI) Shares Bought by Schroder Investment Management Group

Schroder Investment Management Group raised its holdings in Masimo Co. (NASDAQ:MASI) by 38.4% during the fourth quarter, HoldingsChannel.com reports. The firm owned 468,020 shares of the medical equipment provider’s stock after purchasing an additional 129,905 shares during the period. Schroder Investment Management Group’s holdings in Masimo were worth $39,687,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. USA Mutuals Advisors Inc. purchased a new stake in shares of Masimo in the 4th quarter valued at $110,000. SeaCrest Wealth Management LLC purchased a new stake in shares of Masimo in the 4th quarter valued at $116,000. DekaBank Deutsche Girozentrale raised its holdings in shares of Masimo by 78.3% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 2,106 shares of the medical equipment provider’s stock valued at $182,000 after buying an additional 925 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Masimo by 39.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,820 shares of the medical equipment provider’s stock valued at $239,000 after buying an additional 802 shares during the period. Finally, Jane Street Group LLC purchased a new stake in shares of Masimo in the 3rd quarter valued at $317,000. Institutional investors own 82.18% of the company’s stock.

In related news, EVP Yongsam Lee sold 10,000 shares of the business’s stock in a transaction on Friday, January 5th. The stock was sold at an average price of $88.17, for a total transaction of $881,700.00. Following the completion of the transaction, the executive vice president now directly owns 75,018 shares of the company’s stock, valued at approximately $6,614,337.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Sanford Fitch sold 2,000 shares of the business’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $93.07, for a total value of $186,140.00. Following the transaction, the director now directly owns 68,249 shares of the company’s stock, valued at $6,351,934.43. The disclosure for this sale can be found here. Insiders have sold a total of 48,098 shares of company stock valued at $4,315,261 over the last three months. 16.60% of the stock is currently owned by insiders.

Several equities research analysts recently issued reports on MASI shares. Zacks Investment Research upgraded Masimo from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a report on Thursday, November 2nd. Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price objective on shares of Masimo in a report on Friday, November 3rd. Finally, BidaskClub downgraded Masimo from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $104.60.

Masimo Co. (MASI) opened at $85.40 on Thursday. Masimo Co. has a one year low of $80.69 and a one year high of $104.71. The company has a market capitalization of $4,422.02, a price-to-earnings ratio of 32.79, a P/E/G ratio of 3.25 and a beta of 0.85.

TRADEMARK VIOLATION NOTICE: This story was first published by BBNS and is the property of of BBNS. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://baseballnewssource.com/markets/masimo-co-masi-shares-bought-by-schroder-investment-management-group/1903515.html.

Masimo Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped
Mother of Pittsburgh Pirates Player Elias Diaz Has Been Kidnapped


Leave a Reply

 
© 2006-2018 BBNS.